- Home
- /Benzodiazepines confirm method
Benzodiazepines confirm method
Confirms the presence of benzodiazepines in urine using advanced detection methods.
Why This Biomarker Matters
Confirmatory testing verifies benzodiazepine use, medication compliance, and detects unauthorized use in clinical, occupational, or forensic settings with high accuracy.
Overview
This confirmatory urine test detects the presence of benzodiazepines, a class of sedative medications used to treat anxiety, insomnia, and seizures. The 'confirm method' uses advanced laboratory techniques (such as mass spectrometry) to definitively identify benzodiazepines, rather than screening tests that may give false positives. This test is used in clinical settings to verify medication use, monitor compliance with prescribed benzodiazepines, and in forensic or occupational health contexts to detect unauthorized use. It provides a reliable, specific identification of benzodiazepine presence.
Technical Information (LOINC Codes)
Standardized laboratory codes for this biomarker
19286-4PrimaryAvailable Lab Tests
Order tests that measure this biomarker